Opportunity Knocking,
Since you brought it up, the following are three current BioCurex truths that should concern investors.
1. As of yesterday, Dr. Moro has ceased answering any questions submitted from shareholders on the company message board. Here is verbatim what he said: “As soon as we have concrete and material information ... we'll make it available via the appropriate channels.”
2. As per yesterday’s SEC Form S-8, 10 million newly registered shares of BioCurex common stock have the potential to be sold by employees, directors, officers, consultants, and advisors on the open market at any time.
3. A large monthly payment to the lien holder of essentially all of BioCurex’s assets is due next week. BioCurex has not made any of these monthly payments for the past five consecutive months, and there is no indication that BioCurex will be able to make this next payment.
kag
